StockNews.com upgraded shares of Orthofix Medical (NASDAQ:OFIX – Free Report) from a hold rating to a buy rating in a report published on Friday. Other equities analysts have also recently issued ...

Julie Andrews, the Chief Financial Officer of Orthofix Medical (TASE:PMCN) Inc. (NASDAQ:OFIX), recently sold a portion of her holdings in the company. According to a recent filing, Andrews sold 4,655 ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25, ...

Julie Andrews, Orthofix's CFO, sold 4,655 shares of common stock on Jan. 16, according to a Jan. 21 SEC filing.

The Orthofix SpinalStim you’re seeing here was given to me by a friend after their doctor said the therapy could be cut short. This provided a somewhat rare opportunity to observe the device ...

Canaccord Genuity initiates coverage on Orthofix Medical with a Buy rating and $24 price target, citing growth potential and strong financial outlook.

Fintel reports that on January 22, 2025, Canaccord Genuity initiated coverage of Orthofix Medical (NasdaqGS:OFIX) with a Buy ...

Shares of Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the five analysts that are covering the firm, MarketBeat.com reports.

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment ...

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...